PMDA — authorised 20 January 2022
- Marketing authorisation holder: IDORSIA PHARMACEUTICALS JAPAN LTD
- Status: approved
🇯🇵 Pivlaz in Japan
PMDA authorised Pivlaz on 20 January 2022
Marketing authorisations
PMDA
- Application: Pivlaz
- Local brand name: Pivlaz
- Status: approved
Pivlaz in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in Japan
Frequently asked questions
Is Pivlaz approved in Japan?
Yes. PMDA authorised it on 20 January 2022; PMDA has authorised it.
Who is the marketing authorisation holder for Pivlaz in Japan?
IDORSIA PHARMACEUTICALS JAPAN LTD holds the Japanese marketing authorisation.